Editor-in-Chief Dr. Glenn Eisen highlights this article from the September issue: “A risk index for advanced neoplasia on the second surveillance colonoscopy in patients with previous adenomatous polyps” by Thomas F. Imperiale, MD, Ravi Juluri, MD, Eric A. Sherer, PhD, Elizabeth A. Glowinski, RN, Cynthia S. Johnson, MS, and Michael S. Morelli, MD.
Recommendations for surveillance colonoscopy in patients with previous neoplasia are based on evidence and guidelines, but similar recommendations for the timing of surveillance colonoscopy beyond the first surveillance are based on less evidence. Dr. Imperiale and colleagues saw the need for a risk index to help tailor surveillance in these patients.
The authors have derived and validated a risk index that uses patient age and findings from the index colonoscopy and first surveillance colonoscopy to stratify the risk of finding advanced neoplasia on the second surveillance colonoscopy.
Guidelines for surveillance intervals after the initial identification of nonadvanced adenoma recommend an interval of 5 to 10 years, but the findings of these authors indicate that for people at low risk of advanced neoplasia, the interval can be closer to 10 years. If their findings are validated in other settings, this index could help tailor surveillance.
Read the article abstract here.
Watch Dr. Imperiale’s author interview video.
The information presented in Endoscopedia reflects the opinions of the authors and does not represent the position of the American Society for Gastrointestinal Endoscopy (ASGE). ASGE expressly disclaims any warranties or guarantees, expressed or implied, and is not liable for damages of any kind in connection with the material, information, or procedures set forth.